Search research articles
Contact Us
Filters
Showing results (61-70 of 212) with videos related to
Page
of 22
Sort By:
Haematologica
|
September 13, 2005
Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation
Giovanni Barosi, Angelo Carella, Mario Lazzarino, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 5, 2015
Safety and efficacy of single-agent bendamustine after failure of brentuximab vedotin in patients with relapsed or refractory hodgkin's lymphoma: experience with 27 patients
Pier Luigi Zinzani, Umberto Vitolo, Simonetta Viviani, et al.
Cancer
|
April 22, 2011
The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens
Giulia Benevolo, Alessandra Larocca, Massimo Gentile, et al.
Cancer
|
September 21, 2004
Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linformi
Fortunato Morabito, Andrea Gallamini, Caterina Stelitano, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 7, 2013
Radiation therapy in primary mediastinal B-cell lymphoma with positron emission tomography positivity after rituximab chemotherapy
Andrea Riccardo Filippi, Cristina Piva, Francesca Giunta, et al.
Leukemia & Lymphoma
|
July 7, 2009
Long term outcome of localized aggressive non-Hodgkin lymphoma treated with a short weekly chemotherapy regimen (doxorubicin, cyclophosphamide, bleomycin, vincristine, and prednisone) and involved field radiotherapy: result of a Gruppo Italiano Multiregionale per lo Studio dei Linfomi e Leucenie (GIMURELL) study
Maria Giuseppina Cabras, Angela Maria Mamusa, Umberto Vitolo, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 12, 2016
Potential Benefit of Involved-Field Radiotherapy for Patients With Relapsed-Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation
Mario Levis, Cristina Piva, Andrea Riccardo Filippi, et al.
Leukemia & Lymphoma
|
October 6, 2012
Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy
Andrea Riccardo Filippi, Angela Botticella, Marilena Bellò, et al.
Haematologica
|
March 9, 2004
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia
Davide Rossi, Daniela Capello, Annunziata Gloghini, et al.
American Journal of Clinical Pathology
|
July 26, 2005
Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas
Andrea D Manazza, Lisa Bonello, Marco Pagano, et al.
Page
of 22
Search research articles
Search
Showing results (61-70 of 212) with videos related to
Sort By:
Page
of 22
Haematologica
|
September 13, 2005
Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation
Giovanni Barosi, Angelo Carella, Mario Lazzarino, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 5, 2015
Safety and efficacy of single-agent bendamustine after failure of brentuximab vedotin in patients with relapsed or refractory hodgkin's lymphoma: experience with 27 patients
Pier Luigi Zinzani, Umberto Vitolo, Simonetta Viviani, et al.
Cancer
|
April 22, 2011
The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens
Giulia Benevolo, Alessandra Larocca, Massimo Gentile, et al.
Cancer
|
September 21, 2004
Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linformi
Fortunato Morabito, Andrea Gallamini, Caterina Stelitano, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 7, 2013
Radiation therapy in primary mediastinal B-cell lymphoma with positron emission tomography positivity after rituximab chemotherapy
Andrea Riccardo Filippi, Cristina Piva, Francesca Giunta, et al.
Leukemia & Lymphoma
|
July 7, 2009
Long term outcome of localized aggressive non-Hodgkin lymphoma treated with a short weekly chemotherapy regimen (doxorubicin, cyclophosphamide, bleomycin, vincristine, and prednisone) and involved field radiotherapy: result of a Gruppo Italiano Multiregionale per lo Studio dei Linfomi e Leucenie (GIMURELL) study
Maria Giuseppina Cabras, Angela Maria Mamusa, Umberto Vitolo, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 12, 2016
Potential Benefit of Involved-Field Radiotherapy for Patients With Relapsed-Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation
Mario Levis, Cristina Piva, Andrea Riccardo Filippi, et al.
Leukemia & Lymphoma
|
October 6, 2012
Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy
Andrea Riccardo Filippi, Angela Botticella, Marilena Bellò, et al.
Haematologica
|
March 9, 2004
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia
Davide Rossi, Daniela Capello, Annunziata Gloghini, et al.
American Journal of Clinical Pathology
|
July 26, 2005
Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas
Andrea D Manazza, Lisa Bonello, Marco Pagano, et al.
Page
of 22